Evidence map›Paper›PMID 26156515›Full record

ArticleNeurology2015

Diabetes and cognitive decline in a French cohort of patients infected with HIV-1.

Carole Dufouil, Laura Richert, Rodolphe Thiébaut, Mathias Bruyand, Hélène Amieva, Frédéric-Antoine Dauchy, Jean-François Dartigues, Didier Neau, Philippe Morlat, Patrick Dehail and 4 more

Abstract read
In one paragraph

Article in Neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Neurocognitive Impairment and Associated Genetic Aspects in HIV Infection.Current topics in behavioral neurosciences · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Carole DufouilFrom INSERM (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.), Centre INSERM U897 and CIC-1401, Bordeaux School of Public Health; University of Bordeaux (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.); and Public Health Department (C.D., L.R., R.T., M.B., F.D., G.C.), Internal Medicine and Infectious Disease Department (F.-A.D., P.M., P.D., F.B.), Neurology Department (J.-F.D.), and Infectious and Tropical Diseases Federation (D.N.), Bordeaux Hospital, France. carole.dufouil@inserm.fr.
Laura RichertFrom INSERM (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.), Centre INSERM U897 and CIC-1401, Bordeaux School of Public Health; University of Bordeaux (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.); and Public Health Department (C.D., L.R., R.T., M.B., F.D., G.C.), Internal Medicine and Infectious Disease Department (F.-A.D., P.M., P.D., F.B.), Neurology Department (J.-F.D.), and Infectious and Tropical Diseases Federation (D.N.), Bordeaux Hospital, France.
Rodolphe ThiébautFrom INSERM (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.), Centre INSERM U897 and CIC-1401, Bordeaux School of Public Health; University of Bordeaux (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.); and Public Health Department (C.D., L.R., R.T., M.B., F.D., G.C.), Internal Medicine and Infectious Disease Department (F.-A.D., P.M., P.D., F.B.), Neurology Department (J.-F.D.), and Infectious and Tropical Diseases Federation (D.N.), Bordeaux Hospital, France.
Mathias BruyandFrom INSERM (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.), Centre INSERM U897 and CIC-1401, Bordeaux School of Public Health; University of Bordeaux (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.); and Public Health Department (C.D., L.R., R.T., M.B., F.D., G.C.), Internal Medicine and Infectious Disease Department (F.-A.D., P.M., P.D., F.B.), Neurology Department (J.-F.D.), and Infectious and Tropical Diseases Federation (D.N.), Bordeaux Hospital, France.
Hélène AmievaFrom INSERM (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.), Centre INSERM U897 and CIC-1401, Bordeaux School of Public Health; University of Bordeaux (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.); and Public Health Department (C.D., L.R., R.T., M.B., F.D., G.C.), Internal Medicine and Infectious Disease Department (F.-A.D., P.M., P.D., F.B.), Neurology Department (J.-F.D.), and Infectious and Tropical Diseases Federation (D.N.), Bordeaux Hospital, France.
Frédéric-Antoine DauchyFrom INSERM (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.), Centre INSERM U897 and CIC-1401, Bordeaux School of Public Health; University of Bordeaux (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.); and Public Health Department (C.D., L.R., R.T., M.B., F.D., G.C.), Internal Medicine and Infectious Disease Department (F.-A.D., P.M., P.D., F.B.), Neurology Department (J.-F.D.), and Infectious and Tropical Diseases Federation (D.N.), Bordeaux Hospital, France.
Jean-François DartiguesFrom INSERM (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.), Centre INSERM U897 and CIC-1401, Bordeaux School of Public Health; University of Bordeaux (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.); and Public Health Department (C.D., L.R., R.T., M.B., F.D., G.C.), Internal Medicine and Infectious Disease Department (F.-A.D., P.M., P.D., F.B.), Neurology Department (J.-F.D.), and Infectious and Tropical Diseases Federation (D.N.), Bordeaux Hospital, France.
Didier NeauFrom INSERM (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.), Centre INSERM U897 and CIC-1401, Bordeaux School of Public Health; University of Bordeaux (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.); and Public Health Department (C.D., L.R., R.T., M.B., F.D., G.C.), Internal Medicine and Infectious Disease Department (F.-A.D., P.M., P.D., F.B.), Neurology Department (J.-F.D.), and Infectious and Tropical Diseases Federation (D.N.), Bordeaux Hospital, France.
Philippe MorlatFrom INSERM (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.), Centre INSERM U897 and CIC-1401, Bordeaux School of Public Health; University of Bordeaux (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.); and Public Health Department (C.D., L.R., R.T., M.B., F.D., G.C.), Internal Medicine and Infectious Disease Department (F.-A.D., P.M., P.D., F.B.), Neurology Department (J.-F.D.), and Infectious and Tropical Diseases Federation (D.N.), Bordeaux Hospital, France.
Patrick DehailFrom INSERM (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.), Centre INSERM U897 and CIC-1401, Bordeaux School of Public Health; University of Bordeaux (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.); and Public Health Department (C.D., L.R., R.T., M.B., F.D., G.C.), Internal Medicine and Infectious Disease Department (F.-A.D., P.M., P.D., F.B.), Neurology Department (J.-F.D.), and Infectious and Tropical Diseases Federation (D.N.), Bordeaux Hospital, France.
François DabisFrom INSERM (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.), Centre INSERM U897 and CIC-1401, Bordeaux School of Public Health; University of Bordeaux (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.); and Public Health Department (C.D., L.R., R.T., M.B., F.D., G.C.), Internal Medicine and Infectious Disease Department (F.-A.D., P.M., P.D., F.B.), Neurology Department (J.-F.D.), and Infectious and Tropical Diseases Federation (D.N.), Bordeaux Hospital, France.
Fabrice BonnetFrom INSERM (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.), Centre INSERM U897 and CIC-1401, Bordeaux School of Public Health; University of Bordeaux (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.); and Public Health Department (C.D., L.R., R.T., M.B., F.D., G.C.), Internal Medicine and Infectious Disease Department (F.-A.D., P.M., P.D., F.B.), Neurology Department (J.-F.D.), and Infectious and Tropical Diseases Federation (D.N.), Bordeaux Hospital, France.
Geneviève ChêneFrom INSERM (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.), Centre INSERM U897 and CIC-1401, Bordeaux School of Public Health; University of Bordeaux (C.D., L.R., R.T., M.B., H.A., J.-F.D., P.M., P.D., F.D., F.B., G.C.); and Public Health Department (C.D., L.R., R.T., M.B., F.D., G.C.), Internal Medicine and Infectious Disease Department (F.-A.D., P.M., P.D., F.B.), Neurology Department (J.-F.D.), and Infectious and Tropical Diseases Federation (D.N.), Bordeaux Hospital, France.
ANRS CO3 Aquitaine Study Group
Université de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe investigated the relationship of diabetes and prediabetes with cognitive performances, assessed through raw test and z scores and according to neurocognitive impairment (NCI) classification in a cohort of individuals infected with HIV.

methodsThe ANRS CO3 Aquitaine cohort is a prospective hospital-based cohort of HIV-1-infected patients under routine clinical management in 6 public hospitals in southwestern France. Between 2007 and 2009, an ancillary study consisted of a neuropsychological battery of 10 tests at baseline and 2-year follow-up. The severity of NCI (normal, asymptomatic, mild, HIV dementia) was assessed according to international guidelines.

resultsAt baseline (400 patients, 33 with prediabetes, 39 with diabetes), in cross-sectional multivariable analyses, patients with diabetes performed significantly worse on 9 neuropsychological tests that assessed memory, executive functions, attention, psychomotor speed, language, and manual dexterity. Participants with prediabetes had worse performances compared with those who had normal glycemia in 5 tests. The longitudinal analysis of the association between glycemia status at baseline and change in cognitive performances over 2-year follow-up (n = 283) suggested that patients with diabetes also showed a slightly higher decline on 5 of the 10 tests, those involving executive functions and memory functioning. Glycemia status at baseline was not significantly associated with NCI severity in cross-sectional (p = 0.44) and longitudinal (p = 0.64) analyses.

conclusionsIn this hospital-based cohort of people living with HIV, diabetes, but not the other cardiovascular risk factors, is associated with worse cognitive performances in several cognitive domains and with larger decline in fewer domains over the short term.

Indexed as

HIV-1AdultCognition DisordersCohort StudiesCross-Sectional StudiesDiabetes MellitusFemaleFollow-Up StudiesFranceHIV InfectionsHumansLongitudinal StudiesMaleMiddle AgedProspective Studies

Identifiers

PMID26156515
PMCPMC4603596
OpenAlexW2102793808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.